US first lady Jill Biden has tested positive in a rebound case of COVID-19 but is not experiencing any symptoms, while President Joe Biden continues to...
The White House on Thursday announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue...
Pfizer is spending more than $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own. The New York...
Pfizer on Friday said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at preventing coronavirus infection in people living with...
A pill to treat COVID-19 appears to be the country’s best hope, outside of vaccines and strong public health measures, to keep hospitals from being overrun...
Health Canada has authorized the use of Pfizer’s COVID-19 antiviral treatment Paxlovid, the first oral and at-home prescription medication to be cleared for use in this...
Pfizer Inc has signed a $5.29 billion deal with the US government to deliver 10 million courses of its COVID-19 oral antiviral drug starting this year,...